ResMed Inc recorded record revenue and income for the quarter ended June 30, 2010, driven by strong sales of the S9 AutoSet and Elite products, and robust mask sales.

"In the fourth quarter of fiscal 2010, we continued to show strong growth year-over-year in the Americas, as well as in international markets,” said Kieran T. Gallahue, president and CEO. “Our favorable mix of product sales and market share gains led to a 20% revenue increase in the Americas over the prior year’s quarter, resulting in $160.9 million in sales. Revenue outside the Americas increased by 11% to $130.7 million over the prior year’s quarter, or a 16% increase on a constant currency basis. Globally, our growth in flow generators was mainly driven by strong sales of the new S9™ AutoSet and Elite products. Mask sales were particularly robust this quarter across all categories and across all geographies.”

Revenue for the quarter ended June 30, 2010, was $291.6 million, a 16% increase (an 18% increase on a constant currency basis) over the quarter ended June 30, 2009. For the quarter ended June 30, 2010, income from operations was $68.6 million and net income was $53.2 million, an increase of 19% and 17%, respectively, compared to the quarter ended June 30, 2009.
For the year, revenue was $1.1 billion, a 19% increase over the year ended June 30, 2009.

"Surpassing the billion dollar mark in annual sales is a result of our ability to continue to innovate and launch new products to treat sleep-disordered breathing,” said Gallahue. “We believe continued growth will also come from the increasing confirmation of the strong impact of the relationship between sleep-disordered breathing, obstructive sleep apnea, and co-morbidities such as cardiac disease, diabetes, hypertension, and obesity.”